JPMORGAN CHASE & CO - G MED INNOVATIONS HLDGS LTD ownership

G MED INNOVATIONS HLDGS LTD's ticker is GMVD and the CUSIP is G39462208. A total of 8 filers reported holding G MED INNOVATIONS HLDGS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of G MED INNOVATIONS HLDGS LTD
ValueSharesWeighting
Q3 2022$14,000
-61.1%
60,1640.0%0.00%
Q2 2022$36,000
-52.6%
60,1640.0%0.00%
Q1 2022$76,000
-24.8%
60,164
-0.8%
0.00%
Q4 2021$101,000
-26.3%
60,661
-0.4%
0.00%
Q3 2021$137,000
-38.0%
60,879
+1.2%
0.00%
Q2 2021$221,00060,1640.00%
Other shareholders
G MED INNOVATIONS HLDGS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Tradewinds Capital Management, LLC 48,730$62,0000.01%
IFG Advisors, LLC 10,000$13,0000.01%
Virtu Financial LLC 27,264$35,0000.00%
Schonfeld Strategic Advisors LLC 117,100$149,0000.00%
HighMark Wealth Management LLC 1,650$2,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 38,958$49,0000.00%
CITIGROUP INC 49$00.00%
Citadel Advisors 50,193$64,0000.00%
JPMORGAN CHASE & CO 60,164$76,0000.00%
ROYAL BANK OF CANADA 1,000$1,0000.00%
View complete list of G MED INNOVATIONS HLDGS LTD shareholders